News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Istvan Petak breaks down Genomate Health’s impact on cancer care with Roupen Odabashian on OncoDaily Dialogues
Collage photo of Istvan Petak and Roupen Odabashian
Mar 28, 2025, 16:39

Istvan Petak breaks down Genomate Health’s impact on cancer care with Roupen Odabashian on OncoDaily Dialogues

Genomate Health shared a post on LinkedIn:

“In a minute, Dr. Istvan Petak, Founder and CEO of Genomate Health, breaks down exactly what Genomate does, and why it matters, on OncoDaily Dialogues with Roupen Odabashian, MD, FRCPC, ABIM.

Discover how Genomate is transforming cancer care by making precision oncology accessible, scalable, and clinically actionable.

Watch the full conversation here.”

Proceed to the video attached to the post.

More posts featuring Genomate Health.

cancer Genomate Health Istvan Petak OncoDaily OncoDaily Dialogues Oncology Roupen Odabashian
Special Coverage
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization
Blog
Apr 1, 2025, 14:35
Douglas Flora: The messy truth behind healthcare's coming AI adoption
Blog
Apr 1, 2025, 14:31
Zainab Shinkafi-Bagudu: Processed meats and fried snacks may increase the risk of colorectal cancer
Societies
Apr 1, 2025, 14:08
Myeloma Paper of the Day, April 1st, suggested by Robert Orlowski
Blog
Apr 1, 2025, 12:54
CTOS Communications Committee's survey to understand your engagement with social media
Science
Apr 1, 2025, 12:48
Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL
Blog
Apr 1, 2025, 12:43
By 2040, the global burden of colorectal cancer is expected to rise by 63% - Digestive Cancers Europe
Blog
Apr 1, 2025, 12:34
Asya Agulnik: Breakthrough approaches needed for pediatric cancer treatment in conflict-affected regions
Blog
Apr 1, 2025, 12:18
What if 'No Response' Becomes 'No Recurrence' in Colorectal Cancer Treatment? - CancerWorld